raloxifene
raloxifene is a pharmaceutical drug with 50 clinical trials. Currently 3 active trials ongoing. Historical success rate of 95.3%.
Success Metrics
Based on 41 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
11
Mid Stage
26
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.3%
41 of 43 finished
4.7%
2 ended early
3
trials recruiting
50
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
Clinical Trials (50)
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
Osteoporosis Treatment in Post-menopausal Women
Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome
Cognition in the Study of Tamoxifen and Raloxifene
DP-R213 Phase 1 Pharmacokinetics Study
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
The Effects of Seasonal Changes in Osteoporosis Treatment
DP-R213 Pharmacokinetics Study
The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 50